Skip to content

Creatine Supplementation for Female Football

Creatine Supplementation in Young and Elite Female Football Players

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06250556
Enrollment
70
Registered
2024-02-09
Start date
2024-02-10
Completion date
2024-12-30
Last updated
2024-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletes

Brief summary

Creatine is an effective, inexpensive, and safe dietary supplement, which has been largely used in sports and clinical populations. However, creatine is much less studied in female athletes, with long-term data being particularly scant. This study aims to expand our knowledge on the effects of creatine supplementation in young (Under-20) and elite female football players. This study will comprise two experiments. The first one will be a randomized, controlled trial in which young athletes will be assigned into either creatine or placebo (n = 20). Before and 7 days after supplementation or placebo (4 x 5 g/d of Creapure or dextrose at same dose), athletes will perform a battery of performance tests. Blood and urinary biochemical parameters for assessing the safety of supplementation will be analyzed (creatinine, albuminuria, urea, sodium, potassium, liver enzymes, creatine kinase, hematology). Food intake will be assessed by means of 3-d 24-h dietary recalls. The second experiment will have a quasi-experimental design (i.e., pre-to-post), in which both young and elite football players (n = 70) will be supplemented with creatine (4 x 5 g/d for 7 days and then 5 days during the follow-up) and will be assessed for safety using the above-mentioned markers during the regular football season (\ 12 months). Assessments will be carried out at baseline, in the mid-season and after the season.

Interventions

DIETARY_SUPPLEMENTcreatine

creatine supplementation (Creapure)

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

pre-to-post design for experiment 2.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* female football players

Exclusion criteria

* age under 18

Design outcomes

Primary

MeasureTime frameDescription
kidney functionbaseline and after the sport season (~12 months)serum creatinine levels

Secondary

MeasureTime frameDescription
kidney functionbaseline and after the sport season (~12 months)urinary creatinine levels
muscle damagebaseline and after the sport season (~12 months)serum creatine kinase levels
hemogrambaseline and after the sport season (~12 months)platelet count

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026